Shares of Savaria Co. (TSE:SIS – Get Free Report) have been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is C$26.67.
Several research analysts have weighed in on the company. Stifel Nicolaus boosted their price target on Savaria from C$26.00 to C$28.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. National Bankshares raised their target price on shares of Savaria from C$26.00 to C$30.00 in a research note on Monday, December 22nd. Scotiabank boosted their target price on shares of Savaria from C$25.00 to C$26.00 in a report on Monday, November 10th. Finally, TD Securities increased their price target on shares of Savaria from C$24.00 to C$27.00 and gave the company a “buy” rating in a research note on Thursday, November 6th.
Savaria Trading Up 1.6%
Savaria (TSE:SIS – Get Free Report) last released its earnings results on Wednesday, November 5th. The company reported C$0.32 earnings per share (EPS) for the quarter. Savaria had a return on equity of 8.24% and a net margin of 5.34%.The business had revenue of C$224.77 million for the quarter. On average, equities analysts forecast that Savaria will post 1.2048518 EPS for the current fiscal year.
Savaria Company Profile
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Read More
- Five stocks we like better than Savaria
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
